Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2017-05-11
2019-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
C-arm Computed Tomography Scan Image Quality in Patients With Neurovascular Diseases
NCT03162601
CT Coronary Angiography Prior to CTO PCI
NCT05364827
Evaluation of CTCA in Assessing Plaque Pathology and Physiology
NCT03556644
320-slice Coronary Computed Tomography (CT) Angiography
NCT00721851
Plaque Registration and Event Detection In Computed Tomography
NCT00991835
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ischemic Stroke
Percutaneous neurovascular treatment of acute ischemic stroke patients.
Percutaneous treatment of ischemic stroke
An additional C-arm CT imaging scan will be done during neurovascular treatment to evaluate perfusion and collateral vessels in ischemic stroke patients.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous treatment of ischemic stroke
An additional C-arm CT imaging scan will be done during neurovascular treatment to evaluate perfusion and collateral vessels in ischemic stroke patients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subject requires diagnostic and/or interventional imaging in the neuro-angiography suite.
3. Subject or subject's legally authorized representative has signed an institutionally approved research informed consent form.
4. Subject ≥ 18 years old.
Exclusion Criteria
2. Subject with documented contrast medium injection contraindication due to severe kidney disease or allergy.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Philips Healthcare
INDUSTRY
University Health Network, Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vitor Pereira
Associate Professor of Radiology and Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vitor Pereira, MD
Role: PRINCIPAL_INVESTIGATOR
University Health Network - Toronto Western Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Western Hospital - University Health Network
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TWH -Ver. 3.0 March 17 2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.